Pharvaris N.V.
PHVSUnited States
12 filed reports · 235 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
12 reports · Dec 2020 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 177 interim figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · 20-FSEC EDGAR | 6 | 1,461 | Dec 2020 to Dec 2025 |
| Interim · 6-KSEC EDGAR | 6 | 838 | Jun 2022 to Jun 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 6-K | Jun 30, 2026 | Aug 12, 2026 | 311 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Apr 2, 2026 | 473 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Aug 12, 2025 | 4 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Aug 12, 2025 | 144 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Apr 7, 2025 | 205 | Open |
| FY2024 Q2 | 6-K | Jun 30, 2024 | Aug 14, 2024 | 96 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Apr 10, 2024 | 215 | Open |
| FY2023 Q2 | 6-K | Jun 30, 2023 | Aug 7, 2023 | 137 | Open |
| FY2022 | 20-F | Dec 31, 2022 | Apr 5, 2023 | 185 | Open |
| FY2022 Q2 | 6-K | Jun 30, 2022 | Sep 12, 2022 | 146 | Open |
| FY2021 | 20-F | Dec 31, 2021 | Mar 29, 2022 | 174 | Open |
| FY2020 | 20-F | Dec 31, 2020 | Apr 29, 2021 | 209 | Open |
Financial data
235 concepts · 2,299 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial231 concepts · 2,153 facts · Dec 2018 to Jun 2026
- Number of employees27 · Dec 2018 to Jun 2026
- Par value per share23 · Dec 2020 to Jun 2026
- Cash and cash equivalents22 · Dec 2018 to Jun 2026
- Equity22 · Dec 2018 to Jun 2026
- Issued capital22 · Dec 2019 to Jun 2026
- Property plant and equipment21 · Dec 2018 to Jun 2026
- Estimated financial effect of contingent assets20 · Dec 2019 to Jun 2026
- Estimated financial effect of contingent liabilities20 · Dec 2019 to Jun 2026
- Number of share options exercisable in sharebased payment arrangement20 · Dec 2019 to Jun 2026
- Number of shares issued and fully paid20 · Dec 2019 to Jun 2026
- Accruals classified as current19 · Dec 2019 to Jun 2026
- Assets (IFRS)19 · Dec 2019 to Jun 2026
- Current prepayments19 · Dec 2019 to Jun 2026
- Deferred tax assets19 · Dec 2021 to Jun 2026
- Equity and liabilities19 · Dec 2019 to Jun 2026
- Liabilities (IFRS)19 · Dec 2019 to Jun 2026
- Other current assets (IFRS)19 · Dec 2019 to Jun 2026
- Other reserves (IFRS)19 · Dec 2019 to Jun 2026
- Retained earnings19 · Dec 2019 to Jun 2026
- Share premium (IFRS)19 · Dec 2019 to Jun 2026
- Trade and other current payables19 · Dec 2019 to Jun 2026
- Trade and other current payables to trade suppliers19 · Dec 2019 to Jun 2026
- Trade and other current receivables (IFRS)19 · Dec 2019 to Jun 2026
- Value added tax receivables19 · Dec 2019 to Jun 2026
Product2 concepts · 132 facts · Dec 2018 to Jun 2026
- Research and development expense (IFRS)81 · Dec 2018 to Jun 2026
- R&D Expense51 · Jun 2021 to Jun 2026
Geography2 concepts · 14 facts · Dec 2020 to Dec 2025
- Tax effect of tax losses12 · Dec 2020 to Dec 2025
- Applicable tax rate2 · Jun 2021 to Jun 2022
Segments
146 factsFigures broken down by business line, region, product or another axis the company reports on.
Products and services13 members · 132 facts
- Clinical Expenses14 · Dec 2018 to Jun 2026
- Intellectual Property Costs14 · Dec 2018 to Jun 2026
- Manufacturing Costs14 · Dec 2018 to Jun 2026
- Personnel Expenses14 · Dec 2018 to Jun 2026
- Nonclinical Expenses13 · Dec 2019 to Jun 2026
- License Costs9 · Dec 2019 to Jun 2026
- Clinical expenses9 · Jun 2021 to Jun 2026
- Intellectual property costs9 · Jun 2021 to Jun 2026
- Manufacturing costs9 · Jun 2021 to Jun 2026
- Nonclinical expenses9 · Jun 2021 to Jun 2026
- Personnel expenses9 · Jun 2021 to Jun 2026
- License costs6 · Jun 2024 to Jun 2026
- Preclinical Expenses3 · Dec 2018 to Dec 2020
Geographical areas2 members · 12 facts
- CH6 · Dec 2020 to Dec 2025
- NL6 · Dec 2020 to Dec 2025
Statement geographical1 member · 2 facts
- NL2 · Jun 2021 to Jun 2022
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.